T1	p 90 154	healthy volunteers and in patients with primary hypothyroidism .
T2	p 190 205	pineal gland of
T3	p 385 398	man has never
T4	p 474 550	8 healthy volunteers , and 6 women with untreated primary hypothyroidism , a
T5	p 812 835	healthy volunteers were
T6	p 1098 1114	healthy controls
T7	p 1243 1271	patients with hypothyroidism
T8	p 1909 1968	normal subjects and in patients with primary hypothyroidism
T9	p 2084 2092	in man .
T10	i 18 45	somatostatin ( octreotide )
T11	i 67 76	melatonin
T12	i 155 167	Somatostatin
T13	i 291 300	melatonin
T14	i 321 333	somatostatin
T15	i 632 633	.
T16	i 662 685	subcutaneous injections
T17	i 712 755	either saline or octreotide ( Sandostatin ;
T18	i 771 780	50 microg
T19	i 842 852	octreotide
T20	i 855 864	melatonin
T21	i 929 937	saline .
T22	i 1126 1141	octreotide ( GH
T23	i 1173 1183	octreotide
T24	i 1208 1216	h during
T25	i 1329 1350	octreotide and saline
T26	i 1510 1520	octreotide
T27	i 1557 1567	octreotide
T28	i 1589 1597	h during
T29	i 1655 1665	octreotide
T30	i 1756 1770	somatostatin .
T31	i 1777 1802	exogenous somatostatin --
T32	i 1818 1831	octreotide --
T33	o 190 202	pineal gland
T34	o 461 470	secretion
T35	o 599 618	nocturnal secretion
T36	o 865 874	secretion
T37	o 947 964	urinary excretion
T38	o 1046 1058	GH secretion
T39	o 1139 1145	GH AUC
T40	o 1351 1370	. Urinary excretion
T41	o 1420 1431	secretion .
T42	o 1436 1468	total nocturnal secretion of TSH
T43	o 1523 1540	TSH AUC 562+/-136
T44	o 1851 1892	nocturnal secretion and urinary excretion